Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CV Therapeutics logo — company profile

CV Therapeutics

Founded 1991 United States Palo Alto, United States 468 employees Undisclosed Biotechnology, Health Care +2

General Information

Company Name CV Therapeutics
Founded Year 1991
Location United States Palo Alto, United States
Employees 468
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Undisclosed
Social

Get notified when CV Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CV Therapeutics

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.

No funding data available for CV Therapeutics yet.

Get notified when CV Therapeutics raises funding

CV Therapeutics Alternatives & Competitors

CV Therapeutics vs
Myogen
Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

Series D
Biopharma, Biotechnology
Compare CV Therapeutics vs Myogen
CV Therapeutics vs
Corsera Health
Corsera Health

Extending Healthspan by Predicting and Preventing Cardiovascular Disease

Series A
15 employees
Biotechnology, Pharmaceutical
Compare CV Therapeutics vs Corsera Health
CV Therapeutics vs
TransThera | 药捷安康
TransThera | 药捷安康

Transformative Therapy! Innovation for global patients.

Series D
19 employees
Biotechnology, Life Sciences
Compare CV Therapeutics vs TransThera | 药捷安康

FAQ About CV Therapeutics

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine. In April 2009, CV Therapeutics wa...
CV Therapeutics was founded in 1991.
CV Therapeutics is headquartered in Palo Alto, United States.
CV Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Manufacturing.
CV Therapeutics has approximately 468 employees.
Top alternatives and competitors to CV Therapeutics include Myogen, Corsera Health, TransThera | 药捷安康, Aegerion Pharmaceuticals, vasopharm GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CV Therapeutics and Myogen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CV Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy